← Back to feedRead original →
VERIFIEDET Finance·positive
Zydus gearing up for next phase of growth, eyeing new areas: Sharvil Patel, MD
AI Summary
- ·Zydus expects strong earnings from its discovery-led business, oncology, and Saroglitazar from 2030 onwards.
- ·The company anticipates significant value creation from these areas within the next four to five years.
- ·Zydus is exploring new business areas for future growth.